Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

[Clinical evaluation of adherence to antiretroviral therapy in adolescents infected by HIV since infancy].

Vanthournout B, Van Der Kelen E, Elate D, Goetghebuer T, Hainaut M, Levy J.

Arch Pediatr. 2013 Apr;20(4):348-55. doi: 10.1016/j.arcped.2013.01.015. Epub 2013 Mar 1. French.

PMID:
23466406
2.

Viral suppression and adherence among HIV-infected children and adolescents on antiretroviral therapy: results of a multicenter study.

Cruz ML, Cardoso CA, Darmont MQ, Souza E, Andrade SD, D'Al Fabbro MM, Fonseca R, Bellido JG, Monteiro SS, Bastos FI.

J Pediatr (Rio J). 2014 Nov-Dec;90(6):563-71. doi: 10.1016/j.jped.2014.04.007. Epub 2014 Jun 20.

3.

Evaluating adherence to medication in children and adolescents with HIV.

Khan M, Song X, Williams K, Bright K, Sill A, Rakhmanina N.

Arch Dis Child. 2009 Dec;94(12):970-3. doi: 10.1136/adc.2008.156232. Epub 2009 Aug 31.

PMID:
19723637
4.

Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.

Gianotti N, Galli L, Bocchiola B, Cahua T, Panzini P, Zandonà D, Salpietro S, Maillard M, Danise A, Pazzi A, Lazzarin A, Castagna A.

HIV Med. 2013 Mar;14(3):153-60. doi: 10.1111/j.1468-1293.2012.01046.x. Epub 2012 Sep 20.

5.

HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients.

Sumari-de Boer IM, Sprangers MA, Prins JM, Nieuwkerk PT.

AIDS Behav. 2012 Aug;16(6):1681-9. doi: 10.1007/s10461-011-0112-y.

6.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
7.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.

8.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
9.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
10.

Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus.

Shingadia D, Viani RM, Yogev R, Binns H, Dankner WM, Spector SA, Chadwick EG.

Pediatrics. 2000 Jun;105(6):E80.

PMID:
10835093
11.

Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.

Berg KM, Litwin AH, Li X, Heo M, Arnsten JH.

Clin Infect Dis. 2011 Nov;53(9):936-43. doi: 10.1093/cid/cir537. Epub 2011 Sep 2.

12.

Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.

Glikman D, Walsh L, Valkenburg J, Mangat PD, Marcinak JF.

Pediatrics. 2007 May;119(5):e1142-8. Epub 2007 Apr 23.

PMID:
17452493
13.

Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIV.

Chandwani S, Koenig LJ, Sill AM, Abramowitz S, Conner LC, D'Angelo L.

J Adolesc Health. 2012 Sep;51(3):242-51. doi: 10.1016/j.jadohealth.2011.12.013. Epub 2012 Mar 3.

PMID:
22921134
14.

Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.

Gibb DM, Goodall RL, Giacomet V, McGee L, Compagnucci A, Lyall H; Paediatric European Network for Treatment of AIDS Steering Committee.

Pediatr Infect Dis J. 2003 Jan;22(1):56-62.

PMID:
12544410
15.

Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.

MacDonell K, Naar-King S, Huszti H, Belzer M.

AIDS Behav. 2013 Jan;17(1):86-93. doi: 10.1007/s10461-012-0364-1.

16.

Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.

Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR; Adolescent Medicine HIV/AIDS Research Network.

Arch Pediatr Adolesc Med. 2005 Aug;159(8):764-70.

PMID:
16061785
17.

Interventions to improve adherence to antiretroviral therapy in children with HIV infection.

Bain-Brickley D, Butler LM, Kennedy GE, Rutherford GW.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009513. doi: 10.1002/14651858.CD009513. Review.

PMID:
22161452
18.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23. Spanish.

PMID:
22633764
19.

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G.

Ann Intern Med. 2007 Apr 17;146(8):564-73.

PMID:
17438315
Items per page

Supplemental Content

Write to the Help Desk